Steward Partners Investment Advisory, LLC Allakos Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $9.37 Billion
- Q2 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Allakos Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 1,500 shares of ALLK stock, worth $2,115. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,500
Previous 1,500
-0.0%
Holding current value
$2,115
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ALLK
# of Institutions
96Shares Held
70.7MCall Options Held
43.8KPut Options Held
1.4K-
Bvf Inc San Francisco, CA16.6MShares$23.3 Million0.51% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$8.67 Million0.58% of portfolio
-
Deep Track Capital, LP Greenwich, CT5MShares$7.05 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$4.96 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.42MShares$4.83 Million0.0% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $119M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...